Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

Scientists have developed a simple, new test that can identify the early stages of one kind of cancer. What can you understand by listening to the news from the BBC World Service?

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions ...

Researchers from the University of Birmingham’s Bladder Cancer Research Centre have used a new method to detect chemical changes in the DNA in an individual’s urine sample - epigenetic changes, called ...

Blood in the urine, medically referred to as haematuria, is a symptom that can understandably cause concern. While it is ...

The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap." ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...